CYP19A1 and breast carcinoma: Although other polymorphisms in the CYP17 and CYP19 genes have been reported, we focused on these two polymorphisms because they have been studied most extensively both in relation to their potential associations with breast cancer and also in relation to their influence on circulating estrogens.